証拠の質 4.88/5
8次元のレビュー評価。基準は 品質ルーブリック 。各次元は1〜5で評価。
- D1 出典への根拠
- 4/5
- D2 出典の権威性
- 5/5
- D3 算術
- 5/5
- D4 不確実性
- 5/5
- D5 範囲
- 5/5
- D6 文章
- 5/5
- D7 認識の誠実性
- 5/5
- D8 注意事項の完全性
- 5/5
リスクはどう変わるか
見出しの数値は大きく異なる状況の平均です。シナリオや文脈による確率の違いは以下の通りです:
—
No epidemiological study has measured attributable disease from dietary or airborne microplastic exposure in the general US population. Exposure is real; harm is unquantified.
—
Workers in synthetic textile and plastics manufacturing have higher inhalation exposure. Some occupational studies report elevated respiratory symptoms (flock worker's lung), but these involve specific fiber types at industrial concentrations, not general microplastic exposure. Signal is weak and confounded by co-exposures.
—
Shellfish and small pelagic fish bioaccumulate microplastics. Consumers of large quantities of mussels, oysters, and sardines have higher ingestion estimates, but no cohort study has linked this dietary pattern to measurable health outcomes in humans.
—
Bottled water contains roughly 10-100x more microplastic particles per liter than tap water in most studies, likely from packaging. WHO's 2019 review found no health risk from either source at observed levels.
バーの長さと濃淡は、これらのシナリオを他のリスクとではなく、互いに比較して順位付けしたものです。正確な確率は各項目の横に表示されています。
マイクロプラスチックに関する懸念と証拠の間の隔たりは大きいですが、その方向性は異例です。懸念は、科学がマイクロプラスチックは安全だと言っていることではなく、科学がまだ具体的な行動につながるようなことをほとんど何も言っていないことです。WHOの2019年の飲料水中のマイクロプラスチックに関するレビューでは、現在の曝露レベルにおいて健康リスクの「信頼できる証拠はない」と結論付けられました。EFSAは100以上の研究をレビューした後も、定量化されたリスク数値を発表しておらず、2027年末まで正式な見解をまとめる予定はありません。一般集団レベルでの食事性または空気中のマイクロプラスチック曝露に起因するヒトの疾患を測定した疫学コホートはありません。この項目がno_reliable_estimateとなっているのは、リスクがゼロだと分かっているからではなく、誰もそれを数値化できるほど十分に測定していないからです。
懸念を駆り立てるのは、「検出=危険」というヒューリスティックです。Leslie et al. (2022) は、ヒトの血液サンプルの77%からマイクロプラスチック粒子を発見しました。これは全身曝露を証明する真に驚くべき発見です。Ragusa et al. は胎盤からそれらを発見しました。NEJMに掲載されたMarfella et al. (2024) は、頸動脈プラークに検出可能なマイクロプラスチックおよびナノプラスチックを持つ患者が、持たない患者と比較して心血管イベントの発生率が4.5倍高かったと報告しました。しかし、Marfellaの研究コホートは事前に選択されており(全員が手術を必要とする無症候性頸動脈疾患を持っていました)、研究には手術環境における汚染防止対策が欠けており、疾患のある集団における関連性は一般の人々における因果関係ではありません。一方、世間の認識を定着させた「週にクレジットカード1枚分」という曝露の主張は、実際の摂取量を1桁から2桁過大評価していることが示されています。現実的な推定値は週あたり0.01〜0.1グラムであり、5グラムではありません。
その数値はまだ存在せず、それはどんな仮の数値よりも重要です。職業曝露(繊維・プラスチック作業者が工業的濃度で合成繊維を吸入する場合)は、呼吸器系への影響について薄いながらも確かな証拠がありますが、これは複合曝露によって交絡されています。魚介類を多く摂取する人は、貝類の生物濃縮を通じてより多くの粒子を摂取します。ボトル入りの水は、水道水よりも1リットルあたりおよそ10〜100倍多くの粒子を供給します。これらの曝露勾配のいずれも、ヒトにおける測定可能な健康転帰とは結びついていません。この分野は疫学以前の段階です。曝露が普遍的であることは分かっており、動物モデルやin-vitroモデルから生物学的妥当性を疑っています。そして、示唆に富むものの方法論的に異論のある関連性研究が1つあります。それは何もないわけではありませんが、確率でもありません。
関連する豆知識
マイクロプラスチックは人の血液、肺、胎盤から見つかり、多くの成人が食品安全の最大級の懸念に挙げています。しかしWHOは、現在の曝露水準でマイクロプラスチックが健康を害するという信頼できる証拠を見出していません。検出は測定されたリスクと同じではありません。
根拠台帳
以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。
1/7 件の出典が引用元と一字一句一致することを独立して検証済み
-
[1] World Health Organization — Microplastics in Drinking-Water
Microplastics in Drinking-WaterSee all 3 Likelier entries citing this source →
- 統計値
No reliable evidence that microplastics in drinking water at current exposure levels pose a risk to human health- 抜粋
“"Based on the limited information we have, microplastics in drinking water don't appear to pose a health risk at current levels. But we need to find out more." ”
- 出典データ
- 2019-08-22
- アクセス日
- 2026-04-18 · アーカイブ版
- 計算過程
- WHO reviewed all available evidence on microplastic occurrence in drinking water (tap and bottled) and assessed potential health impacts from ingestion. The report concluded that particles larger than 150 micrometres are unlikely to be absorbed, uptake of smaller particles is expected to be limited, and no epidemiological data link drinking-water microplastic exposure to adverse health outcomes. WHO called for more research but did not identify a quantifiable risk, supporting the no_reliable_estimate classification.
- 独立性
- WHO review synthesised global evidence independently of the Marfella, Leslie, and EFSA analyses cited below.
-
[2] New England Journal of Medicine / Marfella et al. — Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 検証済み
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events- 統計値
Patients with detectable MNPs in carotid plaque had HR 4.53 (95% CI 2.00-10.27) for composite cardiovascular endpoint vs those without- 抜粋
“"Patients in whom microplastics and nanoplastics were detected within the atheroma had a higher risk of a composite of myocardial infarction, stroke, or death from any cause than those in whom microplastics and nanoplastics were not detected." ”
- 出典データ
- 2024-03-07
- アクセス日
- 2026-04-18 · アーカイブ版
- 検証
- グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
- 計算過程
- Marfella et al. prospectively followed 257 patients who underwent carotid endarterectomy and analyzed excised plaque for MNPs via pyrolysis-GC/MS. Polyethylene was detected in 58.4% of plaques (150 of 257); PVC in 12.1% (31 patients). After 34 months, the MNP-positive group had significantly higher cardiovascular events. However, this is an observational study in a high-risk surgical cohort (all had asymptomatic carotid disease), and critics note no pre-analytical anticontamination procedures were used — the surgical environment itself contains PE and PVC. The study demonstrates association in a diseased population, not causation in the general public, and cannot be converted to a population-level attributable risk.
- 独立性
- Prospective clinical cohort study by Italian researchers using pyrolysis-GC/MS on excised plaque tissue; independent of WHO review and Leslie blood-detection study.
-
[3] Environment International / Leslie et al. — Discovery and quantification of plastic particle pollution in human blood
Discovery and quantification of plastic particle pollution in human blood- 統計値
Microplastics detected in 17 of 22 (77%) healthy adult blood samples at mean concentration of 1.6 µg/mL- 抜粋
“"This is the first study to report quantitative data on plastic particle pollution in human blood, showing that plastic particles are bioavailable for uptake into the human bloodstream." ”
- 出典データ
- 2022-03-24
- アクセス日
- 2026-04-18 · アーカイブ版
- 計算過程
- Leslie et al. analyzed blood from 22 healthy Dutch volunteers using pyrolysis-GC/MS for five high-production polymers. PET was the most prevalent (50% of samples), followed by polystyrene (36%) and PE (23%). The study proves systemic exposure (detection) but does not measure health outcomes. No dose-response relationship, no disease endpoint, no follow-up. Detection of a substance in blood is a necessary but not sufficient condition for harm — the dose, persistence, and biological activity all remain unquantified for general-population microplastic exposure. This study is included because it is the most-cited driver of public fear, illustrating the detection-equals-danger heuristic.
- 独立性
- Dutch laboratory study using independent pyrolysis-GC/MS methodology on volunteer blood samples; no overlap with the Marfella clinical cohort or WHO/EFSA reviews.
-
[4] Nature Medicine / Nihart et al. — Bioaccumulation of microplastics in decedent human brains
Bioaccumulation of microplastics in decedent human brains- 統計値
MNP concentration 7-30x higher in brain (median ~4900 µg/g) than liver/kidney; rose ~50% from 2016 to 2024; up to 10x higher in brains with documented dementia- 抜粋
“"Concentrations in decedent brain samples were 7 to 30 times higher than in the liver or kidney... brain tissue from people who had been diagnosed with dementia had up to 10 times as much plastic in their brains as everyone else... the study design cannot show whether higher levels of plastic in the brain caused the dementia symptoms — they may simply accumulate more due to the disease process itself." ”
- 出典データ
- 2025-02-03
- アクセス日
- 2026-06-14 · アーカイブ版
- 計算過程
- Nihart et al. applied pyrolysis-GC/MS (corroborated by FTIR and electron microscopy) to >50 autopsy samples from the Albuquerque medical examiner, from decedents in 2016 and 2024. Brain MNP load (predominantly polyethylene, largely nanoscale shard-like fragments) far exceeded liver and kidney, and rose ~50% across the eight-year window. Brains with a documented dementia diagnosis showed up to 10x more plastic, concentrated in cerebrovascular walls and immune cells. This is a cross-sectional autopsy series: the dementia association is explicitly correlation, not causation, and the authors flag reverse causation (impaired clearance / blood-brain-barrier breakdown in dementia could increase deposition). It quantifies tissue burden and its temporal rise, not attributable disease risk, so it does not change the no_reliable_estimate classification.
- 独立性
- US autopsy-tissue study using pyrolysis-GC/MS plus FTIR and electron microscopy; methodologically independent of the WHO review, the Marfella plaque cohort, the Leslie blood study, and the EFSA assessment.
-
[5] European Food Safety Authority — Microplastics and nanoplastics in food
Microplastics and nanoplastics in food- 統計値
EFSA risk assessment on microplastics in food scheduled for completion by end of 2027; no quantified health risk established as of 2025- 抜粋
“"The European Parliament has requested EFSA to deliver a scientific opinion on the potential health risks posed by microplastics in food, water and air." ”
- 出典データ
- 2025-10-28
- アクセス日
- 2026-04-18 · アーカイブ版
- 計算過程
- EFSA's 2025 literature review of micro- and nanoplastic release from food contact materials analyzed over 100 studies (2015-2025) and concluded that while microplastic release from FCMs is real, current studies likely overestimate quantities, and nanoplastic data remain insufficient for reliable exposure estimates. EFSA has not issued a quantified risk figure. Their formal scientific opinion is not expected until end of 2027. The absence of an EFSA opinion after years of review is itself evidence of the epistemic gap — not of safety, but of insufficient data to quantify risk in either direction.
- 独立性
- EFSA risk assessment is an independent EU regulatory review, methodologically separate from the WHO 2019 review and from individual primary studies.
-
[6] Journal of Hazardous Materials Letters / Pletz (2022) — Ingested Microplastics: Do Humans Eat One Credit Card per Week?
Ingested Microplastics: Do Humans Eat One Credit Card per Week?- 統計値
The widely cited 5g/week estimate overestimates ingestion by several orders of magnitude; realistic estimates are 0.01-0.1g/week- 抜粋
“"Our analysis suggests that the widely reported figure of 5 g per week overestimates microplastic ingestion by several orders of magnitude." ”
- 出典データ
- 2022-12-01
- アクセス日
- 2026-04-18 · アーカイブ版
- 計算過程
- Pletz (2022) critically reviewed the Senathirajah et al. (2021) analysis that generated the "credit card per week" claim. The 5g figure was the extreme upper bound of a 0.1-5g range, and the underlying methodology conflated particle counts with mass in ways that inflate estimates. More careful analyses suggest typical adult ingestion is roughly 0.01-0.1g per week — still nonzero, but 50-500x lower than the headline figure. This matters because the perceived threat level is anchored to an exposure estimate that is almost certainly wrong by orders of magnitude.
- 独立性
- Critical reanalysis of the WWF/Newcastle exposure estimate by independent food-science researchers; not affiliated with WHO, EFSA, or the original 2019 study authors.
-
[7] Environment International / Ragusa et al. — Plasticenta: First evidence of microplastics in human placenta
Plasticenta: First evidence of microplastics in human placenta- 統計値
12 microplastic fragments (5-10 micrometers) detected via Raman microspectroscopy in 4 of 6 human placentas from uneventful pregnancies- 抜粋
“"In total, 12 microplastic fragments (ranging from 5 to 10 [micrometers] in size)...were found in 4 placentas." ”
- 出典データ
- 2021-01-01
- アクセス日
- 2026-07-03 · アーカイブ版
- 計算過程
- Substantiates the body prose's "Ragusa et al. found them in placentas" claim. First reported detection of microplastics in human placental tissue (fetal side, maternal side, and chorioamniotic membranes) in a small sample of six placentas from uneventful pregnancies. Like the Leslie blood study, this proves detection/bioavailability, not attributable health harm -- no outcome data, no dose-response, no disease endpoint measured. Does not change the no_reliable_estimate classification.
- 独立性
- Italian clinical/laboratory study using Raman microspectroscopy on placental tissue; methodologically independent of the WHO review, the Marfella plaque cohort, the Leslie blood study, the Nihart brain study, and the EFSA assessment.